Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Merck
Dow
Harvard Business School
McKesson

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Warsaw Orthopedic Inc v. NuVasive Inc (S.D. Cal. 2012)

See Plans and Pricing

« Back to Dashboard

Warsaw Orthopedic Inc v. NuVasive Inc (S.D. Cal. 2012)

Docket   Start Trial Date Filed 2012-11-09
Court District Court, S.D. California Date Terminated
Cause 35:0271 Patent Infringement Assigned To Cathy Ann Bencivengo
Jury Demand Both Referred To Magistrate Judge Mitchell D. D
Parties MEDTRONIC PUERTO RICO OPERATIONS COMPANY; MEDTRONIC SOFAMOR DANEK DEGGENDORF, GMBH; MEDTRONIC SOFAMOR DANEK USA, INC; MEDTRONIC, INC.; NUVASIVE INC; OSTEOTECH INC; WARSAW ORTHOPEDIC, INC.
Patents 3,948,262; 5,134,122
Attorneys Alexander MacKinnon PHV; Craig E Countryman; Frank E Scherkenbach PHV; John David LaDue; Jonathan J. Lamberson; Keeley Irene Vega; Luke L Dauchot PHV; Matthew J Elliott; Michael Ari Amon; Michael Ari Amon PHV; Michael J Kane; Neil A. Warren; Nimalka R Wickramasekera PHV; Nimalka R. Wickramasekera; Paul D Tripodi; Sharre S. Lotfollahi; Timothy Michael Curran; Todd Glen Miller PHV
Link to Docket External link to docket
Small Molecule Drugs cited in Warsaw Orthopedic Inc v. NuVasive Inc
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Warsaw Orthopedic Inc v. NuVasive Inc (S.D. Cal. 2012)

Date Filed Document No. Description Snippet Link To Document
2013-07-24 83 patent is extended or adjusted under 35 3,948,262 A 4/… 4,664,567 A 5/1987 Edwards 3,948,262 A 4/1976 Zaffaroni … 5,360,430 A 1111994 Lin 3,948,262 A 4/1976 Zaffaroni … Apr. 17,2009. suantto PatentL.R. 4.2 for U.S. Patent No. 5,772,661 U.S. Patent No. Medtronic Sofamor…Contentions Regarding U.S. Patent Nos. suant to Patent L.R. 4.2 for U.S. Patent Nos. 6,592,586: 5,860,973 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
Medtronic
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.